Cargando…

NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2

Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Marušić, Marinko, Paić, Matej, Knobloch, Mia, Liberati Pršo, Ana-Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904371/
https://www.ncbi.nlm.nih.gov/pubmed/33681089
http://dx.doi.org/10.1155/2021/6613827
_version_ 1783654914580283392
author Marušić, Marinko
Paić, Matej
Knobloch, Mia
Liberati Pršo, Ana-Marija
author_facet Marušić, Marinko
Paić, Matej
Knobloch, Mia
Liberati Pršo, Ana-Marija
author_sort Marušić, Marinko
collection PubMed
description Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in the multifactorial etiopathogenesis of this condition leading to accumulation of free fatty acids in the liver cells, thus causing lipotoxicity, inflammation, and fibrosis. In this review, we will focus on currently known pathogenesis of nonalcoholic fatty liver disease. Numerous investigation strategies are available to establish the diagnosis, from biochemical markers and ultrasound to various molecular and advanced imaging techniques and liver biopsy. Prevention is crucial. However, effective and promising therapies are strongly demanded.
format Online
Article
Text
id pubmed-7904371
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79043712021-03-04 NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2 Marušić, Marinko Paić, Matej Knobloch, Mia Liberati Pršo, Ana-Marija Can J Gastroenterol Hepatol Review Article Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in the multifactorial etiopathogenesis of this condition leading to accumulation of free fatty acids in the liver cells, thus causing lipotoxicity, inflammation, and fibrosis. In this review, we will focus on currently known pathogenesis of nonalcoholic fatty liver disease. Numerous investigation strategies are available to establish the diagnosis, from biochemical markers and ultrasound to various molecular and advanced imaging techniques and liver biopsy. Prevention is crucial. However, effective and promising therapies are strongly demanded. Hindawi 2021-02-17 /pmc/articles/PMC7904371/ /pubmed/33681089 http://dx.doi.org/10.1155/2021/6613827 Text en Copyright © 2021 Marinko Marušić et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Marušić, Marinko
Paić, Matej
Knobloch, Mia
Liberati Pršo, Ana-Marija
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title_full NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title_fullStr NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title_full_unstemmed NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title_short NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
title_sort nafld, insulin resistance, and diabetes mellitus type 2
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904371/
https://www.ncbi.nlm.nih.gov/pubmed/33681089
http://dx.doi.org/10.1155/2021/6613827
work_keys_str_mv AT marusicmarinko nafldinsulinresistanceanddiabetesmellitustype2
AT paicmatej nafldinsulinresistanceanddiabetesmellitustype2
AT knoblochmia nafldinsulinresistanceanddiabetesmellitustype2
AT liberatiprsoanamarija nafldinsulinresistanceanddiabetesmellitustype2